The expression levels of fibroblast growth factor receptor 2 (FGFR2) did not differ statistically between the early-stage and the later-stage MMD group across the five cell clusters and 15 subclusters (Fig. 4A). This evidence concerns the gene FGFR2 and multiminicore myopathy.